Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma: A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study

By Saito Takefumi  

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 51-61

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes: An Overview of Data from PROactive

By Dormandy John  

Drug Safety, Vol. 32, Iss. 3, 2009-01 ,pp. : 187-202

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance Study of the Efficacy and Tolerability of Pioglitazone in Insulin-Resistant Patients with Type 2 Diabetes Mellitus in General Practice

By Schöfl C.  

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 725-734

Adis International

Access to resources Recommend Favorite

Pioglitazone Lowers Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus: An Open, Multicentre, Observational Study

By Konrad Thomas   Lübben Georg   Franzen Christine  

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 337-340

Adis International

Access to resources Recommend Favorite